Hanall Biopharma Co., Ltd. (KRX:009420) Stocks Pounded By 25% But Not Lagging Industry On Growth Or Pricing
Mar 20
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Pharma Industry Analysis
UpdatedMar 21, 2025
DataAggregated Company Financials
Companies102
- 7D0.6%
- 3M3.6%
- 1Y-3.5%
- YTD-1.4%
Last week, the Pharma industry hasn't moved much but Yuhan is up 8.9% in that time. Unfortunately though, the industry is down 3.5% over the past 12 months. Looking forward, earnings are forecast to grow by 26% annually.
Industry Valuation and Performance
Has the South Korean Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 21 Mar 2025 | ₩54.4t | ₩29.6t | ₩925.3b | 14.2x | 58.8x | 1.8x |
| Sun, 16 Feb 2025 | ₩56.2t | ₩29.5t | ₩1.0t | 11.7x | 56x | 1.9x |
| Tue, 14 Jan 2025 | ₩57.4t | ₩29.6t | ₩1.0t | 13.3x | 56.6x | 1.9x |
| Thu, 12 Dec 2024 | ₩50.6t | ₩29.4t | ₩988.7b | 11.8x | 51.2x | 1.7x |
| Sat, 09 Nov 2024 | ₩58.1t | ₩28.7t | ₩841.1b | 15x | 69.1x | 2x |
| Mon, 07 Oct 2024 | ₩60.0t | ₩28.7t | ₩833.2b | 15.2x | 72x | 2.1x |
| Wed, 04 Sep 2024 | ₩60.4t | ₩28.8t | ₩837.9b | 15.6x | 72.1x | 2.1x |
| Fri, 02 Aug 2024 | ₩55.5t | ₩28.4t | ₩762.2b | 14.3x | 72.8x | 2x |
| Sun, 30 Jun 2024 | ₩51.9t | ₩30.0t | ₩904.2b | 13.2x | 57.4x | 1.7x |
| Tue, 28 May 2024 | ₩52.1t | ₩30.1t | ₩897.6b | 14.7x | 58.1x | 1.7x |
| Thu, 25 Apr 2024 | ₩51.5t | ₩29.4t | ₩922.9b | 16.6x | 55.8x | 1.8x |
| Sat, 23 Mar 2024 | ₩55.5t | ₩29.9t | ₩798.2b | 21.4x | 69.5x | 1.9x |
| Mon, 19 Feb 2024 | ₩51.7t | ₩29.6t | ₩593.1b | 21x | 87.2x | 1.8x |
| Wed, 17 Jan 2024 | ₩53.8t | ₩29.6t | ₩588.5b | 23.3x | 91.5x | 1.8x |
| Fri, 15 Dec 2023 | ₩50.3t | ₩29.6t | ₩588.2b | 21.3x | 85.5x | 1.7x |
| Sun, 12 Nov 2023 | ₩48.3t | ₩29.3t | ₩683.4b | 16.7x | 70.7x | 1.6x |
| Tue, 10 Oct 2023 | ₩51.0t | ₩29.3t | ₩683.3b | 17x | 74.7x | 1.7x |
| Thu, 07 Sep 2023 | ₩50.6t | ₩29.3t | ₩683.9b | 16.2x | 74x | 1.7x |
| Sat, 05 Aug 2023 | ₩51.8t | ₩28.8t | ₩884.1b | 22.2x | 58.6x | 1.8x |
| Mon, 03 Jul 2023 | ₩47.5t | ₩28.8t | ₩899.2b | 20.5x | 52.9x | 1.6x |
| Wed, 31 May 2023 | ₩47.6t | ₩28.9t | ₩903.1b | 23x | 52.8x | 1.6x |
| Fri, 28 Apr 2023 | ₩47.3t | ₩28.5t | ₩602.7b | 20.9x | 78.5x | 1.7x |
| Sun, 26 Mar 2023 | ₩44.1t | ₩28.2t | ₩652.0b | 19.2x | 67.6x | 1.6x |
| Tue, 21 Feb 2023 | ₩45.7t | ₩27.7t | ₩743.5b | 20.7x | 61.5x | 1.6x |
| Thu, 19 Jan 2023 | ₩44.5t | ₩28.0t | ₩770.2b | 19.6x | 57.8x | 1.6x |
| Sat, 17 Dec 2022 | ₩47.7t | ₩28.0t | ₩770.2b | 20.1x | 61.9x | 1.7x |
| Mon, 14 Nov 2022 | ₩44.4t | ₩27.3t | ₩701.8b | 20.8x | 63.3x | 1.6x |
| Wed, 12 Oct 2022 | ₩40.3t | ₩27.2t | ₩694.8b | 20x | 57.9x | 1.5x |
| Fri, 09 Sep 2022 | ₩47.6t | ₩27.5t | ₩725.5b | 21.8x | 65.6x | 1.7x |
| Sun, 07 Aug 2022 | ₩52.5t | ₩26.7t | ₩475.9b | 23.6x | 110.2x | 2x |
| Tue, 05 Jul 2022 | ₩46.6t | ₩26.7t | ₩475.9b | 19.9x | 97.9x | 1.7x |
| Thu, 02 Jun 2022 | ₩54.2t | ₩26.7t | ₩468.1b | 24.5x | 115.8x | 2x |
| Sat, 30 Apr 2022 | ₩57.0t | ₩26.1t | ₩674.3b | 27.3x | 84.5x | 2.2x |
| Mon, 28 Mar 2022 | ₩57.3t | ₩25.7t | ₩726.9b | 24.7x | 78.8x | 2.2x |
Price to Earnings Ratio
78.8x
Current Industry PE
- Investors are pessimistic on the South Korean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 58.8x which is lower than its 3-year average PE of 70.3x.
- The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 8.4% per year over the last three years.
- Revenues for these companies have grown 4.8% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare industry?
| KR Market | 2.28% | |
| Healthcare | 0.12% | |
| Pharma | 0.57% | |
| Pharma | 0.57% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A000100 Yuhan | ₩131.10k | 8.9% +₩802.5b | 71.8% | PE139.1x | |
| A068760 Celltrion Pharm | ₩54.10k | 4.4% +₩100.0b | -50.5% | n/a | |
| A214370 Caregen | ₩26.45k | 5.6% +₩68.6b | 17.0% | PE36.2x | |
| A237690 ST PharmLtd | ₩75.90k | 2.0% +₩30.2b | -19.2% | PE47.2x | |
| A003090 Daewoong | ₩20.05k | 3.6% +₩28.2b | -2.2% | PE14.2x |
